UNC5B mediates G2/M phase arrest of bladder cancer cells by binding to CDC14A and P53

Cancer Gene Ther. 2020 Dec;27(12):934-947. doi: 10.1038/s41417-020-0175-x. Epub 2020 May 6.

Abstract

UNC5B is a known tumor suppressor gene in a variety of cancers. As a transmembrane protein, UNC5B also induces apoptosis in a P53-dependent manner. In this study, we demonstrate that UNC5B inhibits proliferation through G2/M phase arrest by mass spectrometry and bioinformatics analysis in bladder cancer cells. By combing with CDC14A and P53, UNC5B dephosphorylated P53 at Ser-315 site. This dephosphorylation facilitated G2/M phase arrest by reducing the expression of cyclin B1 and increasing the expression of p-CDK1, thus inhibiting tumor proliferation. Knockdown of CDC14A suppressed the G2/M phase arrest induced by UNC5B in vitro, and eliminated the inhibitory effect of UNC5B on tumor proliferation in vivo. Our results show that UNC5B-mediated cell cycle arrest may act as a potential treatment for bladder cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Division / physiology
  • Cell Line, Tumor
  • G2 Phase Cell Cycle Checkpoints / physiology
  • Humans
  • Middle Aged
  • Netrin Receptors / metabolism*
  • Protein Tyrosine Phosphatases / metabolism*
  • Tumor Suppressor Protein p53 / metabolism*
  • Urinary Bladder Neoplasms / genetics
  • Urinary Bladder Neoplasms / metabolism*
  • Urinary Bladder Neoplasms / pathology

Substances

  • Netrin Receptors
  • TP53 protein, human
  • Tumor Suppressor Protein p53
  • UNC5B protein, human
  • CDC14A protein, human
  • Protein Tyrosine Phosphatases